Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals-Reference-Cited by-同舟云学术

Preferential Survival of CD4+ T Lymphocytes Engineered with Anti-Human Immunodeficiency Virus (HIV) Genes in HIV-Infected Individuals

Published:2005-09 Issue:9 Volume:16 Page:1065-1074
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Morgan Richard A.¹,Walker Robert²,Carter Charles S.³,Natarajan Ven⁴,Tavel Jorge A.²,Bechtel Chris²,Herpin Betsy²,Muul Linda¹,Zheng Zhili¹,Jagannatha Shyla⁴,Bunnell Bruce A.¹,Fellowes Vicki³,Metcalf Julia A.³,Stevens Randy⁴,Baseler Michael⁴,Leitman Susan F.³,Read Elizabeth J.³,Blaese R. Michael¹,Lane H. Clifford²

Affiliation:

1. National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.

2. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

3. Clinical Center, National Institutes of Health, Bethesda, MD 20892.

4. SAIC-Frederick, Cancer Research and Development Center, Frederick, MD 21702.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2005.16.1065

Reference31 articles.